<DOC>
	<DOCNO>NCT02081950</DOCNO>
	<brief_summary>This pilot , open-label study aim preliminary evaluation enoxaparin bioavailability follow two administration Clexane s.c. dose 80mg , two different period .</brief_summary>
	<brief_title>A Single-Dose Study Examine Within Subject Variability ClexaneÂ® Healthy Adult Subjects Under Fasting Conditions</brief_title>
	<detailed_description />
	<mesh_term>Enoxaparin</mesh_term>
	<criteria>Healthy male female volunteer 18 55 year age . Female subject child bear potential negative pregnancy test Screening Visit willing use 2 effective method contraception Day 1 3 month afterwards . Subject clinically significant abnormal serum biochemistry , haematology , coagulation factor urine examination value within 14 day first dose . Female subject weight &lt; 45 kg male subject weight &lt; 57 kg . Subject clinically relevant abnormal physical finding could interfere objective study . Subject clinically relevant abnormal laboratory value indicative physical illness ; Hemoglobin &lt; 13 g/dL ; Absolute platelet count 100 x 109/L . Subject hypersensitivity idiosyncratic reaction enoxaparin and/or low molecular weight heparin , and/or pork product . Subject relevant history presence significant cardiovascular , pulmonary , hepatic , renal , hematologic , gastrointestinal , endocrine , immunologic , dermatologic , neurologic , psychiatric disease . In addition , history presence : alcoholism drug abuse within past year ; clot disorder ; gastric duodenal ulcer ; hypertension ; retinopathy ; deep venous thrombosis ; pulmonary embolism ; GI bleeding . Subject clinically significant illness within 4 week prior dose . Subject recent use NSAID and/or aspirin ( within 4 week first dose ) use pharmacological agent know significantly induce inhibit drugmetabolizing enzyme within 30 day first dose . No subject may take antibiotic agent know interfere intestinal microflora within 30 day first dose . Subjects medical condition require regular treatment prescription drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>